Head of the EU Delegation to the Republic of Uzbekistan, H.E. Ambassador Eduards Stiprais, emphasized that “it is highly appreciated that the governments of all Central Asian states have been closely cooperating with the EU in implementing the 6th phase of the programme. Let me repeat that your cooperation is a key factor for the programme’s success.”
EU experts presented success stories from their components, as well as the current and planned activities in the fields of policy advice, monitoring of the drug situation, prevention, drug treatment and harm reduction services in 2018-2019.
The future of CADAP was extensively discussed during the meeting. For instance, it is planned to establish drug information systems and National Early Warning System for New Psychoactive Substances.
CADAP will further spread the knowledge on drug prevention quality standards and how to conduct high quality drug prevention. These initiatives will focus on both universal and indicative prevention, using science-based approaches to preventive intervention.
Furthermore, CADAP will develop a series of papers on drug demand reduction issues, including street work, dual pathology (coexistence of psychiatric disorders with substance abuse) and health programmes in community and prison settings.
A panel discussion on the foreseen CADAP extension phase and next steps to further strengthening EU-Central Asia cooperation on drug issues was also included in the agenda of the meeting.